[5-Fluorouracil-induced reticular hyperpigmentation].
Sanz-Sánchez
T
T
Córdoba
S
S
Jiménez-Ayala
B
B
Borbujo
J M
JM
D000230:Adenocarcinoma / Q000188:drug therapy / Q000601:surgery; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001415:Back; D001706:Biopsy; D002430:Cecal Neoplasms / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006229:Hand Dermatoses / Q000139:chemically induced; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000187:drug effects; D008544:Melanocytes / Q000187:drug effects; D008548:Melanosis / Q000139:chemically induced*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin
D000964:Antimetabolites, Antineoplastic; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D009074:Melanocyte-Stimulating Hormones; D002955:Leucovorin; D005472:Fluorouracil